Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

Authors:

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G and Kyriopoulos J.

Publication Type:

Journal Article

Publication Name:

ClinicoEconomics & Outcomes Research

Citation:

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G and Kyriopoulos J. Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece. Clinicoecon Outcomes Res. 2016;8:583-90.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies